Drug intelligence / Profile preview

ceramide

Development stage
Phase 2
Lead developer
Cancer and Leukemia Group B
Modality
Small Molecules
Administration
Topical
01

Overview

Ceramide is a bioactive sphingolipid that serves as a central component of the cell membrane and acts as a potent intracellular signaling molecule. In oncology, ceramide is recognized as a pro-apoptotic mediator; it accumulates in response to various stress stimuli (such as chemotherapy or radiation) to trigger programmed cell death. This specific topical formulation was developed to treat cutaneous breast cancer by delivering ceramide lipids directly to skin-involved tumor sites to induce apoptosis in malignant cells. The mechanism of action involves the activation of protein phosphatase 2A (PP2A) and cathepsin D, which subsequently leads to the inhibition of the Akt survival pathway and the activation of the caspase cascade. The clinical development of this topical ceramide cream was led by the Alliance for Clinical Trials in Oncology (formerly CALGB) under the study identifier CALGB 9872.

Other names
topical ceramide lipidsceramide creamCALGB 9872CALGB9872CALGB-9872
02

Targets

CTSD (Cathepsin D)PP2A (Protein phosphatase 2A)TAFI (Carboxypeptidase B2)AKT (RAC-alpha serine/threonine-protein kinase)

Beyond the preview

Go deeper on ceramide.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on ceramide.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call